SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalculus Vct Regulatory News (CLC)

Share Price Information for Calculus Vct (CLC)

Share Price is delayed by 15 minutes
Get Live Data
53.25    0.00 (0.00%)
Bid:
48.00
Ask:
58.50
Spread: 10.50 (21.875%)
Market Cap: £51.93m
CLC Live PriceLast checked at - London Stock Exchange

Intraday Calculus Vct Share Chart

Result of AGM

26 Jul 2016 18:18

RNS Number : 3181F
Calculus VCT PLC
26 July 2016
Β 

CALCULUS VCT PLC

Results of Annual General meeting

The Company is pleased to announce that at the Annual General Meeting held today, all resolutions were passed on a show of hands including the following special resolutions 8 to 10.

Β 

8. THAT, in addition to all other existing authorities, the directors be and are generally and unconditionally authorised in accordance with section 570 of the Companies Act 2016 (the Act) to allot equity securities (within the meaning of section 560 of the Act) for cash pursuant to the authority conferred by Resolution 7 as if section 561(1) of the Act did not apply to any such allotment, provided that this power shall expire on the conclusion of the annual general meeting of the Company to be held in 2017.

9. THAT, in substitution for existing authorities, the Company be and hereby is empowered to make one or more market purchases within the meaning of section 693(4) of the Act of its own shares (either for cancellation or for the retention as treasury shares for future re-issue or transfer) provided that:

(a) the aggregate number of ordinary shares and/or C shares and/or D shares which may be purchased shall not exceed 710,205, 289,471 or 271,631 respectively or, if lower, such number of shares of the relevant class as shall equal 14.99 per cent of the issued share capital of that class;

(b) the minimum price which may be paid per share is 1p, the nominal value thereof;

(c) the maximum price which may be paid per share is an amount equal to the higher of (a) 105 per cent of the average of the middle market quotation per share (of the relevant class) taken from the London Stock Exchange daily official list for the five business days immediately preceding the day on which such share is to be purchased; and (b) the amount stipulated by Article 5(1) of the Buy Back and Stabilisation Regulation 2003;

(d) the authority conferred by this resolution shall expire on the conclusion of the annual general meeting of the Company to be held in 2017, unless such authority is renewed prior to such time; and

(e) the Company may make a contract to purchase shares under the authority conferred by this resolution prior to the expiry of such authority which will or may be executed wholly or partly after the expiration of such authority and may make a purchase of such shares pursuant to such contract.

10. THAT the Company be and is hereby generally and unconditionally authorised to hold general meetings (other than annual general meetings) on 14 clear days' notice.

Β 

Β 

Β 

Β 

Β 

The proxy votes received on each resolution were as follows

Resolution

In Favour

Against

At Chairman's discretion

Withheld

Β 

Β 

Β 

Β 

Β 

1

679,648

-

4,900

7,000

2

679,648

-

4,900

7,000

3

686,648

-

4,900

-

4

686,648

-

4,900

-

5

686,648

-

4,900

-

6

686,648

-

4,900

-

7

679,648

-

4,900

7,000

8

679,648

7,000

4,900

-

9

676,798

9,850

4,900

-

10

679,648

7,000

4,900

-

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RAGDQLFLQDFFBBD
Date   Source Headline
22nd Apr 20263:39 pmRNSTransaction in Own Shares
31st Mar 20265:55 pmRNSDirectorate change
25th Mar 20262:23 pmRNSIssue of Equity
18th Feb 20263:14 pmRNSIssue of Equity
22nd Jan 20269:29 amRNSTransaction in Own Shares
16th Jan 20264:34 pmRNSNet Asset Value(s)
14th Jan 20263:00 pmRNSDividend Declaration
18th Dec 20252:30 pmRNSIssue of Equity
18th Dec 20252:30 pmRNSIssue of Equity
17th Dec 20253:15 pmRNSIssue of Equity
15th Dec 20253:10 pmRNSHalf-year Financial Report
14th Oct 20254:33 pmRNSTransaction in Own Shares
3rd Oct 202511:42 amRNSPublication of a Prospectus
2nd Oct 20254:29 pmRNSIssue of Equity
24th Sep 202511:22 amRNSResult of AGM & Change in Directorship
2nd Sep 20252:48 pmRNSIssue of Equity
28th Aug 202512:38 pmRNSPublication of Supplementary Prospectus
27th Aug 20252:52 pmRNSNet Asset Value
31st Jul 20259:46 amRNSAnnual Report with updated dividend details
30th Jul 202511:31 amRNSAnnual Financial Report &Related Party Transaction
3rd Jul 20259:17 amRNSIssue of Equity
10th Jun 20254:41 pmRNSTransaction in Own Shares
5th Jun 20254:39 pmRNSTransaction in Own Shares
4th Apr 20255:15 pmRNSIssue of Equity
26th Mar 20253:21 pmRNSIssue of Equity
11th Mar 20255:11 pmRNSChange of auditor
20th Feb 20254:30 pmRNSIssue of Equity
12th Feb 20254:39 pmRNSTransaction in Own Shares
21st Jan 20255:11 pmRNSNet Asset Value(s)
10th Jan 20253:46 pmRNSIssue of Equity update
18th Dec 20244:24 pmRNSIssue of Equity - 18 December 2024
5th Dec 20245:25 pmRNSHalf-year Report
14th Oct 20241:40 pmRNSPublication of a Prospectus
8th Oct 20245:23 pmRNSTransaction in Own Shares
9th Sep 202411:48 amRNSStatement re Intention to Fund Raise
29th Aug 20245:32 pmRNSIssue of Equity
22nd Aug 20244:27 pmRNSResults of Annual General Meeting
31st Jul 20245:44 pmRNSIssue of Equity
17th Jul 20241:51 pmRNSNet Asset Value(s)
11th Jul 20245:38 pmRNSAnnual Financial Report
24th Apr 20244:49 pmRNSTransaction in Own Shares
5th Apr 20242:54 pmRNSIssue of Equity - 5 April 2024
22nd Feb 20244:38 pmRNSDirectorship Change
15th Feb 202411:53 amRNSIssue of Equity - 15 February 2024
1st Feb 20244:38 pmRNSNet Asset Value - 31 December 2023
10th Jan 20245:27 pmRNSTransaction in Own Shares
21st Dec 202310:08 amRNSDirectorate Change
15th Dec 20233:25 pmRNSIssue of Equity - 15 December 2023
20th Nov 20232:11 pmRNSSeptember 2023 NAV Announcement
13th Nov 20234:46 pmRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.